...
首页> 外文期刊>Saudi Pharmaceutical Journal >Diabetes treatment: A rapid review of the current and future scope of stem cell research
【24h】

Diabetes treatment: A rapid review of the current and future scope of stem cell research

机译:糖尿病治疗:干细胞研究当前和未来范围的快速回顾

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Diabetes mellitus is a major health concern of the developing and developed nations across the globe. This devastating disease accounts for the 5% deaths around the world annually. The current treatment methods do not address the underlying causes of the disease and have severe limitations. Stem cells are unique cells with the potential to differentiate into any type of specialized cells. This feature of both adult and embryonic stem cells was explored in great detail by the scientists around the world and are successful in producing insulin secreting cells. The different type of stem cells (induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs) and adult stem cells) proves to be potent in treating diabetes with certain limitations. This article precisely reviews the resources and progress made in the field of stem cell research for diabetic treatment.
机译:糖尿病是全球发展中国家和发达国家关注的主要健康问题。这种毁灭性疾病占全世界每年5%的死亡人数。当前的治疗方法不能解决疾病的根本原因并且具有严重的局限性。干细胞是独特的细胞,具有分化成任何类型的专门细胞的潜力。世界各地的科学家对成体和胚胎干细胞的这一特征进行了详尽的研究,并成功地产生了胰岛素分泌细胞。事实证明,不同类型的干细胞(诱导多能干细胞(iPSC),胚胎干细胞(ESC)和成人干细胞)在治疗糖尿病方面具有一定的局限性。本文恰好回顾了糖尿病治疗干细胞研究领域的资源和进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号